 | • レポートコード：QYR2104Z3454 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、肝硬変症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アルコール性肝硬変症、萎縮性肝硬変症、胆汁性肝硬変症、心臓性肝硬変症、クリプトジェニック肝硬変症）、用途別市場規模（病院、専門クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・肝硬変症の市場動向 ・企業の競争状況、市場シェア ・肝硬変症の種類別市場規模（アルコール性肝硬変症、萎縮性肝硬変症、胆汁性肝硬変症、心臓性肝硬変症、クリプトジェニック肝硬変症） ・肝硬変症の用途別市場規模（病院、専門クリニック） ・肝硬変症の北米市場規模2016-2027（アメリカ、カナダ） ・肝硬変症のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・肝硬変症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・肝硬変症の中南米市場規模2016-2027（メキシコ、ブラジル） ・肝硬変症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（F Hoffman La-Roche、GlaxoSmithKline、Gilead Sciences、Johnson & Johnson、Merck、Bristol-Myers Squibb、Conatus Pharmaceuticals、Gwo Xi Stem Cell Applied Technology、Instituto Grifols、Intercept Pharmaceuticals） ・結論 |
Cirrhosis is scarring of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcohol abuse.
Alcohol has been identified as the strongest risk factor for liver cirrhosis.
Market Analysis and Insights: Global Liver Cirrhosis Market
The global Liver Cirrhosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Liver Cirrhosis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Liver Cirrhosis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Liver Cirrhosis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Liver Cirrhosis market.
Global Liver Cirrhosis Scope and Market Size
Liver Cirrhosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Liver Cirrhosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Alcoholic Cirrhosis
Atrophic Cirrhosis
Biliary Cirrhosis
Cardiac Cirrhosis
Cryptogenic Cirrhosis
Segment by Application
Hospitals
Specialty Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
F Hoffman La-Roche
GlaxoSmithKline
Gilead Sciences
Johnson & Johnson
Merck
Bristol-Myers Squibb
Conatus Pharmaceuticals
Gwo Xi Stem Cell Applied Technology
Instituto Grifols
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liver Cirrhosis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Alcoholic Cirrhosis
1.2.3 Atrophic Cirrhosis
1.2.4 Biliary Cirrhosis
1.2.5 Cardiac Cirrhosis
1.2.6 Cryptogenic Cirrhosis
1.3 Market by Application
1.3.1 Global Liver Cirrhosis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Liver Cirrhosis Market Perspective (2016-2027)
2.2 Liver Cirrhosis Growth Trends by Regions
2.2.1 Liver Cirrhosis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Liver Cirrhosis Historic Market Share by Regions (2016-2021)
2.2.3 Liver Cirrhosis Forecasted Market Size by Regions (2022-2027)
2.3 Liver Cirrhosis Industry Dynamic
2.3.1 Liver Cirrhosis Market Trends
2.3.2 Liver Cirrhosis Market Drivers
2.3.3 Liver Cirrhosis Market Challenges
2.3.4 Liver Cirrhosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liver Cirrhosis Players by Revenue
3.1.1 Global Top Liver Cirrhosis Players by Revenue (2016-2021)
3.1.2 Global Liver Cirrhosis Revenue Market Share by Players (2016-2021)
3.2 Global Liver Cirrhosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Liver Cirrhosis Revenue
3.4 Global Liver Cirrhosis Market Concentration Ratio
3.4.1 Global Liver Cirrhosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liver Cirrhosis Revenue in 2020
3.5 Liver Cirrhosis Key Players Head office and Area Served
3.6 Key Players Liver Cirrhosis Product Solution and Service
3.7 Date of Enter into Liver Cirrhosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Liver Cirrhosis Breakdown Data by Type
4.1 Global Liver Cirrhosis Historic Market Size by Type (2016-2021)
4.2 Global Liver Cirrhosis Forecasted Market Size by Type (2022-2027)
5 Liver Cirrhosis Breakdown Data by Application
5.1 Global Liver Cirrhosis Historic Market Size by Application (2016-2021)
5.2 Global Liver Cirrhosis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Liver Cirrhosis Market Size (2016-2027)
6.2 North America Liver Cirrhosis Market Size by Type
6.2.1 North America Liver Cirrhosis Market Size by Type (2016-2021)
6.2.2 North America Liver Cirrhosis Market Size by Type (2022-2027)
6.2.3 North America Liver Cirrhosis Market Size by Type (2016-2027)
6.3 North America Liver Cirrhosis Market Size by Application
6.3.1 North America Liver Cirrhosis Market Size by Application (2016-2021)
6.3.2 North America Liver Cirrhosis Market Size by Application (2022-2027)
6.3.3 North America Liver Cirrhosis Market Size by Application (2016-2027)
6.4 North America Liver Cirrhosis Market Size by Country
6.4.1 North America Liver Cirrhosis Market Size by Country (2016-2021)
6.4.2 North America Liver Cirrhosis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Liver Cirrhosis Market Size (2016-2027)
7.2 Europe Liver Cirrhosis Market Size by Type
7.2.1 Europe Liver Cirrhosis Market Size by Type (2016-2021)
7.2.2 Europe Liver Cirrhosis Market Size by Type (2022-2027)
7.2.3 Europe Liver Cirrhosis Market Size by Type (2016-2027)
7.3 Europe Liver Cirrhosis Market Size by Application
7.3.1 Europe Liver Cirrhosis Market Size by Application (2016-2021)
7.3.2 Europe Liver Cirrhosis Market Size by Application (2022-2027)
7.3.3 Europe Liver Cirrhosis Market Size by Application (2016-2027)
7.4 Europe Liver Cirrhosis Market Size by Country
7.4.1 Europe Liver Cirrhosis Market Size by Country (2016-2021)
7.4.2 Europe Liver Cirrhosis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Liver Cirrhosis Market Size (2016-2027)
8.2 Asia-Pacific Liver Cirrhosis Market Size by Type
8.2.1 Asia-Pacific Liver Cirrhosis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Liver Cirrhosis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Liver Cirrhosis Market Size by Type (2016-2027)
8.3 Asia-Pacific Liver Cirrhosis Market Size by Application
8.3.1 Asia-Pacific Liver Cirrhosis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Liver Cirrhosis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Liver Cirrhosis Market Size by Application (2016-2027)
8.4 Asia-Pacific Liver Cirrhosis Market Size by Region
8.4.1 Asia-Pacific Liver Cirrhosis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Liver Cirrhosis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Liver Cirrhosis Market Size (2016-2027)
9.2 Latin America Liver Cirrhosis Market Size by Type
9.2.1 Latin America Liver Cirrhosis Market Size by Type (2016-2021)
9.2.2 Latin America Liver Cirrhosis Market Size by Type (2022-2027)
9.2.3 Latin America Liver Cirrhosis Market Size by Type (2016-2027)
9.3 Latin America Liver Cirrhosis Market Size by Application
9.3.1 Latin America Liver Cirrhosis Market Size by Application (2016-2021)
9.3.2 Latin America Liver Cirrhosis Market Size by Application (2022-2027)
9.3.3 Latin America Liver Cirrhosis Market Size by Application (2016-2027)
9.4 Latin America Liver Cirrhosis Market Size by Country
9.4.1 Latin America Liver Cirrhosis Market Size by Country (2016-2021)
9.4.2 Latin America Liver Cirrhosis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liver Cirrhosis Market Size (2016-2027)
10.2 Middle East & Africa Liver Cirrhosis Market Size by Type
10.2.1 Middle East & Africa Liver Cirrhosis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Liver Cirrhosis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Liver Cirrhosis Market Size by Type (2016-2027)
10.3 Middle East & Africa Liver Cirrhosis Market Size by Application
10.3.1 Middle East & Africa Liver Cirrhosis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Liver Cirrhosis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Liver Cirrhosis Market Size by Application (2016-2027)
10.4 Middle East & Africa Liver Cirrhosis Market Size by Country
10.4.1 Middle East & Africa Liver Cirrhosis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Liver Cirrhosis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 F Hoffman La-Roche
11.1.1 F Hoffman La-Roche Company Details
11.1.2 F Hoffman La-Roche Business Overview
11.1.3 F Hoffman La-Roche Liver Cirrhosis Introduction
11.1.4 F Hoffman La-Roche Revenue in Liver Cirrhosis Business (2016-2021)
11.1.5 F Hoffman La-Roche Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Liver Cirrhosis Introduction
11.2.4 GlaxoSmithKline Revenue in Liver Cirrhosis Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Liver Cirrhosis Introduction
11.3.4 Gilead Sciences Revenue in Liver Cirrhosis Business (2016-2021)
11.3.5 Gilead Sciences Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Liver Cirrhosis Introduction
11.4.4 Johnson & Johnson Revenue in Liver Cirrhosis Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Liver Cirrhosis Introduction
11.5.4 Merck Revenue in Liver Cirrhosis Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Liver Cirrhosis Introduction
11.6.4 Bristol-Myers Squibb Revenue in Liver Cirrhosis Business (2016-2021)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Conatus Pharmaceuticals
11.7.1 Conatus Pharmaceuticals Company Details
11.7.2 Conatus Pharmaceuticals Business Overview
11.7.3 Conatus Pharmaceuticals Liver Cirrhosis Introduction
11.7.4 Conatus Pharmaceuticals Revenue in Liver Cirrhosis Business (2016-2021)
11.7.5 Conatus Pharmaceuticals Recent Development
11.8 Gwo Xi Stem Cell Applied Technology
11.8.1 Gwo Xi Stem Cell Applied Technology Company Details
11.8.2 Gwo Xi Stem Cell Applied Technology Business Overview
11.8.3 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Introduction
11.8.4 Gwo Xi Stem Cell Applied Technology Revenue in Liver Cirrhosis Business (2016-2021)
11.8.5 Gwo Xi Stem Cell Applied Technology Recent Development
11.9 Instituto Grifols
11.9.1 Instituto Grifols Company Details
11.9.2 Instituto Grifols Business Overview
11.9.3 Instituto Grifols Liver Cirrhosis Introduction
11.9.4 Instituto Grifols Revenue in Liver Cirrhosis Business (2016-2021)
11.9.5 Instituto Grifols Recent Development
11.10 Intercept Pharmaceuticals
11.10.1 Intercept Pharmaceuticals Company Details
11.10.2 Intercept Pharmaceuticals Business Overview
11.10.3 Intercept Pharmaceuticals Liver Cirrhosis Introduction
11.10.4 Intercept Pharmaceuticals Revenue in Liver Cirrhosis Business (2016-2021)
11.10.5 Intercept Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Liver Cirrhosis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Alcoholic Cirrhosis
Table 3. Key Players of Atrophic Cirrhosis
Table 4. Key Players of Biliary Cirrhosis
Table 5. Key Players of Cardiac Cirrhosis
Table 6. Key Players of Cryptogenic Cirrhosis
Table 7. Global Liver Cirrhosis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Liver Cirrhosis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Liver Cirrhosis Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Liver Cirrhosis Market Share by Regions (2016-2021)
Table 11. Global Liver Cirrhosis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Liver Cirrhosis Market Share by Regions (2022-2027)
Table 13. Liver Cirrhosis Market Trends
Table 14. Liver Cirrhosis Market Drivers
Table 15. Liver Cirrhosis Market Challenges
Table 16. Liver Cirrhosis Market Restraints
Table 17. Global Liver Cirrhosis Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Liver Cirrhosis Market Share by Players (2016-2021)
Table 19. Global Top Liver Cirrhosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Cirrhosis as of 2020)
Table 20. Ranking of Global Top Liver Cirrhosis Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Liver Cirrhosis Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Liver Cirrhosis Product Solution and Service
Table 24. Date of Enter into Liver Cirrhosis Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Liver Cirrhosis Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Liver Cirrhosis Revenue Market Share by Type (2016-2021)
Table 28. Global Liver Cirrhosis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Liver Cirrhosis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Liver Cirrhosis Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Liver Cirrhosis Revenue Market Share by Application (2016-2021)
Table 32. Global Liver Cirrhosis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Liver Cirrhosis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Liver Cirrhosis Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Liver Cirrhosis Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Liver Cirrhosis Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Liver Cirrhosis Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Liver Cirrhosis Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Liver Cirrhosis Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Liver Cirrhosis Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Liver Cirrhosis Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Liver Cirrhosis Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Liver Cirrhosis Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Liver Cirrhosis Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Liver Cirrhosis Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Liver Cirrhosis Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Liver Cirrhosis Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Liver Cirrhosis Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Liver Cirrhosis Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Liver Cirrhosis Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Liver Cirrhosis Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Liver Cirrhosis Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Liver Cirrhosis Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Liver Cirrhosis Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Liver Cirrhosis Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Liver Cirrhosis Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Liver Cirrhosis Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Liver Cirrhosis Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Liver Cirrhosis Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Liver Cirrhosis Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Liver Cirrhosis Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Liver Cirrhosis Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Liver Cirrhosis Market Size by Country (2022-2027) & (US$ Million)
Table 64. F Hoffman La-Roche Company Details
Table 65. F Hoffman La-Roche Business Overview
Table 66. F Hoffman La-Roche Liver Cirrhosis Product
Table 67. F Hoffman La-Roche Revenue in Liver Cirrhosis Business (2016-2021) & (US$ Million)
Table 68. F Hoffman La-Roche Recent Development
Table 69. GlaxoSmithKline Company Details
Table 70. GlaxoSmithKline Business Overview
Table 71. GlaxoSmithKline Liver Cirrhosis Product
Table 72. GlaxoSmithKline Revenue in Liver Cirrhosis Business (2016-2021) & (US$ Million)
Table 73. GlaxoSmithKline Recent Development
Table 74. Gilead Sciences Company Details
Table 75. Gilead Sciences Business Overview
Table 76. Gilead Sciences Liver Cirrhosis Product
Table 77. Gilead Sciences Revenue in Liver Cirrhosis Business (2016-2021) & (US$ Million)
Table 78. Gilead Sciences Recent Development
Table 79. Johnson & Johnson Company Details
Table 80. Johnson & Johnson Business Overview
Table 81. Johnson & Johnson Liver Cirrhosis Product
Table 82. Johnson & Johnson Revenue in Liver Cirrhosis Business (2016-2021) & (US$ Million)
Table 83. Johnson & Johnson Recent Development
Table 84. Merck Company Details
Table 85. Merck Business Overview
Table 86. Merck Liver Cirrhosis Product
Table 87. Merck Revenue in Liver Cirrhosis Business (2016-2021) & (US$ Million)
Table 88. Merck Recent Development
Table 89. Bristol-Myers Squibb Company Details
Table 90. Bristol-Myers Squibb Business Overview
Table 91. Bristol-Myers Squibb Liver Cirrhosis Product
Table 92. Bristol-Myers Squibb Revenue in Liver Cirrhosis Business (2016-2021) & (US$ Million)
Table 93. Bristol-Myers Squibb Recent Development
Table 94. Conatus Pharmaceuticals Company Details
Table 95. Conatus Pharmaceuticals Business Overview
Table 96. Conatus Pharmaceuticals Liver Cirrhosis Product
Table 97. Conatus Pharmaceuticals Revenue in Liver Cirrhosis Business (2016-2021) & (US$ Million)
Table 98. Conatus Pharmaceuticals Recent Development
Table 99. Gwo Xi Stem Cell Applied Technology Company Details
Table 100. Gwo Xi Stem Cell Applied Technology Business Overview
Table 101. Gwo Xi Stem Cell Applied Technology Revenue in Liver Cirrhosis Business (2016-2021) & (US$ Million)
Table 102. Gwo Xi Stem Cell Applied Technology Recent Development
Table 103. Instituto Grifols Company Details
Table 104. Instituto Grifols Business Overview
Table 105. Instituto Grifols Liver Cirrhosis Product
Table 106. Instituto Grifols Revenue in Liver Cirrhosis Business (2016-2021) & (US$ Million)
Table 107. Instituto Grifols Recent Development
Table 108. Intercept Pharmaceuticals Company Details
Table 109. Intercept Pharmaceuticals Business Overview
Table 110. Intercept Pharmaceuticals Liver Cirrhosis Product
Table 111. Intercept Pharmaceuticals Revenue in Liver Cirrhosis Business (2016-2021) & (US$ Million)
Table 112. Intercept Pharmaceuticals Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Liver Cirrhosis Market Share by Type: 2020 VS 2027
Figure 2. Alcoholic Cirrhosis Features
Figure 3. Atrophic Cirrhosis Features
Figure 4. Biliary Cirrhosis Features
Figure 5. Cardiac Cirrhosis Features
Figure 6. Cryptogenic Cirrhosis Features
Figure 7. Global Liver Cirrhosis Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Specialty Clinics Case Studies
Figure 10. Liver Cirrhosis Report Years Considered
Figure 11. Global Liver Cirrhosis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Liver Cirrhosis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Liver Cirrhosis Market Share by Regions: 2020 VS 2027
Figure 14. Global Liver Cirrhosis Market Share by Regions (2022-2027)
Figure 15. Global Liver Cirrhosis Market Share by Players in 2020
Figure 16. Global Top Liver Cirrhosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Cirrhosis as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Liver Cirrhosis Revenue in 2020
Figure 18. Global Liver Cirrhosis Revenue Market Share by Type (2016-2021)
Figure 19. Global Liver Cirrhosis Revenue Market Share by Type (2022-2027)
Figure 20. North America Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Liver Cirrhosis Market Share by Type (2016-2027)
Figure 22. North America Liver Cirrhosis Market Share by Application (2016-2027)
Figure 23. North America Liver Cirrhosis Market Share by Country (2016-2027)
Figure 24. United States Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Liver Cirrhosis Market Share by Type (2016-2027)
Figure 28. Europe Liver Cirrhosis Market Share by Application (2016-2027)
Figure 29. Europe Liver Cirrhosis Market Share by Country (2016-2027)
Figure 30. Germany Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Liver Cirrhosis Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Liver Cirrhosis Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Liver Cirrhosis Market Share by Region (2016-2027)
Figure 40. China Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Liver Cirrhosis Market Share by Type (2016-2027)
Figure 48. Latin America Liver Cirrhosis Market Share by Application (2016-2027)
Figure 49. Latin America Liver Cirrhosis Market Share by Country (2016-2027)
Figure 50. Mexico Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Liver Cirrhosis Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Liver Cirrhosis Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Liver Cirrhosis Market Share by Country (2016-2027)
Figure 56. Turkey Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Liver Cirrhosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. F Hoffman La-Roche Revenue Growth Rate in Liver Cirrhosis Business (2016-2021)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Liver Cirrhosis Business (2016-2021)
Figure 61. Gilead Sciences Revenue Growth Rate in Liver Cirrhosis Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Liver Cirrhosis Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Liver Cirrhosis Business (2016-2021)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Liver Cirrhosis Business (2016-2021)
Figure 65. Conatus Pharmaceuticals Revenue Growth Rate in Liver Cirrhosis Business (2016-2021)
Figure 66. Gwo Xi Stem Cell Applied Technology Revenue Growth Rate in Liver Cirrhosis Business (2016-2021)
Figure 67. Instituto Grifols Revenue Growth Rate in Liver Cirrhosis Business (2016-2021)
Figure 68. Intercept Pharmaceuticals Revenue Growth Rate in Liver Cirrhosis Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の肝硬変症市場規模・現状・予測（2021年-2027年） Cirrhosis is scarring of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcohol abuse. Alcohol has been identified as the strongest risk factor for liver cirrhosis. Market Analysis and Insights: Global Liver Cirrhosis Market The global Liver Cirrhosis …- 世界の非アルコール性脂肪性肝疾患治療市場規模・現状・予測（2021年-2027年） Fatty liver disease refers to the accumulation of fat (triglycerides,) in the liver. The liver cell contains fats, but the accumulation of excess fat can be a cause of concern and can lead to liver inflammation known as steatohepatitis. The fatty liver can be caused by alcohol as well as can be non-…
- 世界の肝疾患治療市場規模・現状・予測（2021年-2027年） Liver disease, greenish-yellow or greenish-brown skin, often due to intrahepatic cholestasis, intrahepatic or extrahepatic biliary obstruction.The sex hormone secreted in liver disease cannot degrade and inactivate in time, which leads to hyperemia and dilatation of superficial arterioles. Market An…
- 世界の肝生検市場規模・現状・予測（2021年-2027年） Liver biopsy is the biopsy (removal of a small sample of tissue) from the liver. It is a medical test that is done to aid diagnosis of liver disease, to assess the severity of known liver disease, and to monitor the progress of treatment. Liver biopsies may be taken percutaneously (via a needle thro…
- 世界の脂肪肝治療市場規模・現状・予測（2021年-2027年） Fatty liver disease is one of the most common liver dysfunction where the triglyceride fat accumulates in liver cells. The major risks associated with fatty liver disease are alcoholic cirrhosis, cardiovascular disorder, metabolic syndrome and biliary cirrhosis among others. Market Analysis and Insi…